Pancreatic Cancer Research

ResearcherVA Connecticut Healthcare SystemNo recent work listed

Gary V. Désir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9289-8978; OpenAlex author ID A5009238890. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0250539↗
  2. Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Last author DOI 10.1038/srep22996↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaojia Guo · 2 shared papers, 2016–2021 · strength 0.17
  2. Charles H. Cha · 2 shared papers, 2016–2021 · strength 0.17
  3. Fred S. Gorelick · 2 shared papers, 2016–2021 · strength 0.17
  4. Melena D. Bellin · 1 shared paper, 2021 · strength 0.12
  5. Yasheen Gao · 1 shared paper, 2021 · strength 0.12
  6. John W. Kunstman · 1 shared paper, 2021 · strength 0.12
  7. Jill Lacy · 1 shared paper, 2021 · strength 0.12
  8. Lindsay L. Hollander · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.